Advertisement

Topics

genOway Germany GmbH Company Profile

18:09 EST 12th December 2018 | BioPortfolio

The development of a new drug costs roughly 800 M.USD. This huge investment has to cover both the development of the drug itself and the cost of unfruitful work. Dead-ends can represent up to 80% of the total cost of a successful drug. Major challenges in the drug development process are (1) to reduce high failure rates due to faulty candidate selection and false positives and (2) to identify all the potential candidates among the false negatives. There are thus great potential savings to be realized by making development more efficient. To help make these savings, genOway designs, develops and markets technologies and proprietary innovative genetically modified biological models. These solutions aim to increase the predictability and throughput of research in target validation, drug screening and pharmacological - toxicological studies.

Location

Grundstrasse 16
Hamburg
20257
Germany

Contact

Phone: 49 (0) 40 40 19 71 00
Fax: 49 (0) 40 43 20 82 61
Email: info@genoway.com.


News Articles [484 Associated News Articles listed on BioPortfolio]

Merck und genOway schließen strategische Allianz zur Entwicklung von Nagetiermodellen unter Einsatz von CRISPR/Cas9

- genOway erwirbt Exklusivrechte an grundlegenden Genomeditierungs-Patenten von Merck für die Erzeugung und den Verkauf von Nagetiermodellen - Entwicklung neuer Technologien und Lösungen mithilfe v....

Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models

- genOway to acquire exclusive rights to Merck's foundational genome-editing patents to produce, sell rodent models - New technologies and solutions to be developed using CRISPR/Cas9 to accelerate...

LenioBio GmbH and Fraunhofer IME to Advance Novel Protein Discoveries Through a License Agreement

DUSSELDORF and AACHEN, Germany, August 1, 2018 /PRNewswire/ -- Life sciences startup LenioBio GmbH and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME Read more...

Global Level Switches Market Status and Outlook 20182025 [Report Updated: 02082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

itelligence Acquires 60-percent Stake in Sybit GmbH

Today, itelligence AGis announcing its acquisition of Sybit GmbH, Germany. Initially, itelligence is acquiring 60 percent of the southern German Hybris and SAP Read more...

Global Particle Counters Market Status and Outlook 20182025 [Report Updated: 01082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Miltenyi Biotec acquires microscopy specialist

Miltenyi Biotec GmbH announced that it has acquired the high-end microscopy specialist LaVision BioTec GmbH. Located in Bielefeld, Germany, LaVision BioTec is a leading global specialist for advanced ...

#Cannabisstocks; Emblem (TSXV:EMC) to Launch Emblem #Germany in Joint Venture with Acnos Pharma

TORONTO - June 20, 2018 (Investorideas.com Newswire) Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) ("Emblem" or the "Company"), is pleased to announce that its Board of Directors has approved th...

PubMed Articles [367 Associated PubMed Articles listed on BioPortfolio]

Field study on loose farrowing in cold barns.

The aim of this field study was to examine the loose farrowing system in view of practicability, particularly to monitor piglet losses and their causes, on a farm proceeding in accordance with the BIO...

Evaluation of the real-world impact of rotational thromboelastometry-guided transfusion protocol in patients undergoing proximal aortic surgery.

Complex aortic procedures are potentially associated with important blood loss and coagulopathy. The aim of this study was to assess the impact of rotational thromboelastometry (ROTEM, Tem Internation...

Disease Prevention and Health Promotion in Germany: A Qualitative Analysis of the Federal Goverment's Coalition Agreement.

The creation of healthful living conditions has contributed to improving health and prolonging life in Germany and worldwide. Despite this progress, avoidable behavioural, occupational and environment...

Correction: Health Impact of the Heatwave of 2015: Hospital Admissions in Frankfurt/Main, Germany.

Future of Regional Health Care in Germany: Where Do Young Dentists Want to Work?

In the context of a shortfall in medical care, the question arises whether a similar trend in dental care may be anticipated. This study analyses preferred working regions and future town-country dist...

Clinical Trials [352 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

The purpose of this study is to confirm a significant influence of ezetimibe and sirolimus on each others pharmacokinetics

Topography-Guided Customized PRK Versus Q-value Adjusted PRK in Correction of Myopia With or Without Astigmatism

This study will include patients who will undergo PRK in both eyes, for each patient each eye will be randomly allocated to one of 2 procedures: topography-guided ablation in one eye (gro...

Companies [973 Associated Companies listed on BioPortfolio]

genOway Germany GmbH

The development of a new drug costs roughly 800 M.USD. This huge investment has to cover both the development of the drug itself and the cost of unfruitful work. Dead-ends can represent up to 80% of t...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Genoway

################

GYMWATCH GmbH

GYMWATCH GmbH develops advanced fitness technologies and devices. Based in Darmstadt, Germany, near Frankfurt, the company’s first product is the patented GYMWATCH Sensor, wh...

Syntesome GmbH

Syntesome GmbH Munich, Germany active in glycobiology and glycotechnology. Catalog includes about 200 products, mainly glycoconjugates.

More Information about "genOway Germany GmbH" on BioPortfolio

We have published hundreds of genOway Germany GmbH news stories on BioPortfolio along with dozens of genOway Germany GmbH Clinical Trials and PubMed Articles about genOway Germany GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of genOway Germany GmbH Companies in our database. You can also find out about relevant genOway Germany GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record